Table 3.
Seronegative | Seropositive | p | |
---|---|---|---|
Typical symptoms, n (%) | 597 (54.6) | 14 (63.6) | 0.52 |
|
108 (9.9) | 8 (36.4) | 0.001 |
|
511 (46.7) | 11 (50.0) | 0.83 |
|
254 (23.2) | 8 (36.4) | 0.12 |
Rhinorrhea, n (%) | 736 (67.3) | 16 (72.7) | 0.65 |
Sore throat, n (%) | 576 (52.7) | 11 (50.0) | 0.83 |
Headache, n (%) | 717 (65.5) | 15 (68.2) | 1.0 |
Abdominal pain, n (%) | 297 (26.9) | 8 (36.4) | 0.34 |
Muscle aches, n (%) | 247 (22.6) | 13 (59.1) | <0.001 |
Nausea, n (%) | 211 (19.3) | 8 (36.4) | 0.06 |
Diarrhea, n (%) | 299 (27.3) | 8 (36.4) | 0.34 |
Respective symptoms as stated by the study participants at SP 1 or SP 2 for the preceding month and at SP 3 for the preceding 2 months. Complete information was provided by a total of 1094 seronegative and 22 seropositive participants.